Hideki Kubo

Platelet Activation in the Cerebral Circulation in Different Subtypes of Ischemic Stroke and Binswanger’s Disease

Toshihiko Iwamoto, Hideki Kubo, Masaru Takasaki · Stroke · 1995 · 88 citations

Coumarins as novel 17β-hydroxysteroid dehydrogenase type 3 inhibitors for potential treatment of prostate cancer

Koichiro Harada, Hideki Kubo, Yoshitaka Tomigahara et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 44 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Urology +9

Identification of oxazolidinediones and thiazolidinediones as potent 17β-hydroxysteroid dehydrogenase type 3 inhibitors

Koichiro Harada, Hideki Kubo, Akio Tanaka et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 21 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +9

Discovery of potent and orally bioavailable 17β-hydroxysteroid dehydrogenase type 3 inhibitors

Koichiro Harada, Hideki Kubo, Jun Abe et al. · Bioorganic & Medicinal Chemistry · 2012 · 17 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +7

The effect of serum on the proliferation of bone marrow-derived mesenchymal stem cells from aged donors and donors with or without chronic heart failure

Hideki Kubo, Kanae Takamura, Noritoshi Nagaya et al. · Journal of Tissue Engineering and Regenerative Medicine · 2016 · 14 citations

Cell Therapy, Heart Failure, Elderly Patients +18